Efficacy and safety of larotrectinib in a pooled analysis of patients (Pts) with tropomyosin receptor kinase (TRK) fusion cancer Meeting Abstract


Authors: Drilon, A.; Shen, L.; van Tilburg, C.; Doz, F.; Tan, D. S. W.; Lin, J. J.; Kummar, S.; Lassen, U. N.; McDermott, R. S.; Dierselhuis, M. P.; Albert, C. M.; Nagasubramanian, R.; Watt, T.; Patil, T.; Burcoveanu, D. I.; Norenberg, R.; Brega, N.; Laetsch, T. W.; Xu, R. H.; Hong, D. S.
Abstract Title: Efficacy and safety of larotrectinib in a pooled analysis of patients (Pts) with tropomyosin receptor kinase (TRK) fusion cancer
Meeting Title: ESMO Congress 2023
Journal Title: Annals of Oncology
Volume: 34
Issue: Suppl. 2
Meeting Dates: 2023 Oct 20-24
Meeting Location: Madrid, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2023-10-01
Start Page: S470
Language: English
ACCESSION: WOS:001087480201010
DOI: 10.1016/j.annonc.2023.09.1854
PROVIDER: wos
Notes: Meeting Abstract: 668P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon